Maria Caturla, PharmD

University of Pennsylvania
Philadelphia, Pennsylvania, United States

Disclosure information not submitted.

Presentation(s):

• 661 - Phase 1, dose-escalation trial of the safety and pharmacokinetics of SARS-CoV-2 DNA-encoded monoclonal antibodies (DMAb) in healthy adults

  Wednesday, October 22, 2025
  3:30 PM - 3:45 PM US ET